This morning, USA-based biotech AirNexis Therapeutics announced its launch with the close of its oversubscribed $200 million ...

New Jersey, USA-based Aquestive Therapeutics saw its shares plummet nearly 48% to $3.25 (Nasdaq: AQST) pre-market today, ...

Noetik, an AI-native biotech company developing self-supervised machine learning and high-throughput spatial data to develop ...

US drugmaker Vanda Pharmaceuticals yesterday announced that it has received a decision letter from the US Food and Drug ...

China-based BioRay Biopharmaceutical has submitted an application to list on the Hong Kong Stock Exchange, setting out plans ...

Chinese pharma Hansoh Pharma (HKEX: 3692) has secured approval from China’s National Medical Products Administration for an ...

US biotech ecosystem company Alloy Therapeutics has appointed Christian Cobaugh as chief executive of its Genetic Medicines ...

Eli Lily has announced positive topline results from the novel TOGETHER-PsA open-label Phase IIIb trial evaluating ...

Danish drug developer Ascendis Pharma yesterday announced top-line results from Week 52 of COACH, the first Phase II clinical ...

US pharma major Pfizer (NYSE: PFE) has struck a non-exclusive research collaboration with Gordian Bio to identify new ...

US commercial stage precision-care company Octave Bioscience has announced the appointment of Kirk Stockwood as senior vice ...

Cambridge, USA-based Parabilis Medicines (formerly FogPharma), a clinical-stage biopharmaceutical company committed to ...